Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED)

Clinical trial NCT00092521 · COMPLETED

Trial details

NCT number: NCT00092521
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cervical Cancer Genital Warts

Start date: 2001-12-01
Primary completion: 2007-07-01
Enrollment: 5759

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.